Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587158 · ClinicalTrials.gov registry record · NA
Oral Paricalcitol in Kidney Transplant Recipients
A NA study of Transplant; Failure, Kidney and Hyperparathyroidism, Secondary, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT00587158 is a NA study of Transplant; Failure, Kidney and Hyperparathyroidism, Secondary that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT00587158, a NA study of Transplant; Failure, Kidney and Hyperparathyroidism, Secondary, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is being done to find out whether patients who receive a kidney transplant can benefit from taking the medication paricalcitol (trade name Zemplar®) as compared to kidney transplant recipients not taking this medication. The main possible benefits being studied are: * Lower risk for overactive parathyroid glands after kidney transplantation. * Lower risk of low bone density in the spine and hip after kidney transplantation. By dividing patients in the study into a group receiving Zemplar® and a group not receiving Zemplar®, it will be possible to understand the good and bad effects of Zemplar® during the first year after a kidney transplant.
Conditions Studied
Interventions
- DRUG Paricalcitol
- OTHER Corticosteroid Avoidance Immune Suppression Protocol
Study Locations (2)
Arizona
- Mayo Clinic - Scottsdale
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587158
The ClinicalTrials.gov registry entry for NCT00587158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Transplant; Failure, Kidney appearing as the primary indexed condition, and to 2 interventions - of which Paricalcitol is the first listed.
NCT00587158 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00587158 about?
NCT00587158 is a clinical study titled "Oral Paricalcitol in Kidney Transplant Recipients". This study is being done to find out whether patients who receive a kidney transplant can benefit from taking the medication paricalcitol (trade name Zemplar®) as compared to kidney transplant recipients not taking this medication. The main possible benefits being studied are: * Lower risk for over...
What is the current status of trial NCT00587158?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2007-01. Estimated completion is 2011-11.
What conditions does trial NCT00587158 study?
This clinical trial studies the following conditions: Transplant; Failure, Kidney, Hyperparathyroidism, Secondary, Renal Disease, End Stage.
What interventions are being tested in trial NCT00587158?
The interventions under investigation include: Paricalcitol (DRUG), Corticosteroid Avoidance Immune Suppression Protocol (OTHER).
Who is sponsoring clinical trial NCT00587158?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00587158 being conducted?
This trial has 2 study locations across Arizona, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transplant; Failure, Kidney
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.